AACR Talk

Some notable quotes from this week’s meeting on cancer research

Written byThe Scientist
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, KWZAs the editors of The Scientist wandered the halls of the Washington, DC, convention center and attended some of the talks given by the 18,000 attendees at this week’s American Association for Cancer Research (AACR) conference, we jotted down some snippets of wisdom—and humor—that we heard. Here are a few of our favorite quotes from this year’s meeting.

Harold Varmus, NCI Director, in a special lecture at AACR

—Rockefeller University President Mark Tessier-Lavigne, speaking about funding cuts to the National Institutes of Health during a rally for biomedical research in Washington, DC

Stephen Friend, Sage Bionetworks, on improving communication between cancer researchers

James Watson, of double-helix fame, speaking about recent rejections from several journals

Jim Doroshow, National Cancer Institute (NCI), in response to Charles Sawyers “provocative questions” about N of 1 trials

Elaine Mardis, Washington University School of Medicine, on her approach to cancer research using a variety of sequencing methods to identify targetable mutations

Andrea Califano, Columbia University, on N of 1 trials

Charles Sawyers, Memorial Sloan-Kettering Cancer Center, on the difficulty getting N of 1 trials published

—Stephen Friend, Sage Bionetworks, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo